000 01207 a2200349 4500
005 20250513120040.0
264 0 _c19970617
008 199706s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI119405
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbernethy, D R
245 0 0 _aGrapefruits and drugs: when is statistically significant clinically significant?
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cMay 1997
300 _a2297-8 p.
_bdigital
500 _aPublication Type: Comment; Editorial; Review
650 0 4 _aAnimals
650 0 4 _aAryl Hydrocarbon Hydroxylases
650 0 4 _aBeverages
650 0 4 _aCitrus
650 0 4 _aCytochrome P-450 CYP3A
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aFelodipine
_xblood
650 0 4 _aHumans
650 0 4 _aMetabolic Clearance Rate
650 0 4 _aNifedipine
_xblood
650 0 4 _aOxidoreductases, N-Demethylating
_xmetabolism
650 0 4 _aPharmacokinetics
650 0 4 _aSmoking
773 0 _tThe Journal of clinical investigation
_gvol. 99
_gno. 10
_gp. 2297-8
856 4 0 _uhttps://doi.org/10.1172/JCI119405
_zAvailable from publisher's website
999 _c9134562
_d9134562